Cecchetti V, Fravolini A, Lorenzini M C, Tabarrini O, Terni P, Xin T
Istituto di Chimica Farmaceutica e Tecnica Farmaceutica, Università di Perugia, Italy.
J Med Chem. 1996 Jan 19;39(2):436-45. doi: 10.1021/jm950558v.
The 6-aminoquinolone had previously been identified as a new class of quinolone antibacterial agents. To continue our structure-activity relationship (SAR) study in this series, novel 6-amino-8-methylquinolone derivatives have now been synthesized and evaluated for in vitro antibacterial activity. We have shown that the coupled presence of a methyl group at the C-8 position with an amino group at C-6 is effective for enhancing antibacterial activity, particularly against Gram-positive bacteria. The SARs associated with the N-1, C-6, and C-7 are discussed. The 1,2,3,4-tetrahydroisoquinolinyl derivative 19v showed the highest antibacterial activity with MIC values on Gram-positive bacteria superior to that of ciprofloxacin, especially against Staphylococcus aureus strains, including those strains which are methicillin-and ciprofloxacin-resistant.
6-氨基喹诺酮此前已被鉴定为一类新型喹诺酮类抗菌剂。为继续我们在该系列中的构效关系(SAR)研究,现已合成了新型6-氨基-8-甲基喹诺酮衍生物,并对其体外抗菌活性进行了评估。我们已经表明,C-8位甲基与C-6位氨基的联合存在对于增强抗菌活性是有效的,特别是对革兰氏阳性菌。讨论了与N-1、C-6和C-7相关的构效关系。1,2,3,4-四氢异喹啉基衍生物19v表现出最高的抗菌活性,其对革兰氏阳性菌的最低抑菌浓度(MIC)值优于环丙沙星,尤其是对金黄色葡萄球菌菌株,包括耐甲氧西林和耐环丙沙星的菌株。